Cowen analyst Charles Rhyee came out to defend Evolent Health (NYSE: EVH) amid the sell-off as Passport misses out on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE